U.S. Senators: Bipartisan proposal to lower drug prices
Senate Finance Committee Chairman and Republican Chuck Grassley and the panel’s leading Democrat, Senator Ron Wyden, announced a bipartisan proposal to lower the Rx drug prices.
Lilly's Combo Therapy Succeeds In Late-Stage Lung Cancer Study
Pfizer Reports Failure in Persistent Pulmonary Hypertension, Progress in Duchenne Muscular Dystrophy
Oklahoma Judge Approves Teva's $85 Million Opioid Settlement
Sanofi To Boost South African Biovac's Vaccine Output
Mylan shares sink as bleak profit outlook for 2019 sparks growth concerns
FDA Approves Botox For Pediatric Patients With Upper Limb Spasticity
AstraZeneca's Farxiga Fails To Receive U.S. Approval For Type 1 Diabetes
Johnson & Johnson To Test Experimental HIV Vaccine In U.S., Europe
Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
GSK Drug Helps Ovarian Cancer Patients Live Longer In Late-Stage Study
Gilead Increases Stake In Galapagos With 10-Year Deal Worth More Than $5 Billion
Lundbeck and Otsuka's antipsychotic drug Rexulti fails two bipolar late-stage studies
AbbVie Dives Into STING
FDA Approves Amgen, Allergan’s Herceptin Biosimilar Kanjinti
High Doses Of Lilly's Trulicity Show Superiority In Reducing Weight, A1C
Amicus, University of Pennsylvania Broaden Gene Therapy Collaboration To Include 12 More Rare Diseases
Alnylam’s RNAi Therapy For Acute Hepatic Porphyria Positive In Phase III
Bayer, Bristol-Myers Squibb, Ono Pharma Partner For Colorectal Cancer Study
Regeneron’s Eylea Wins FDA Approval For Diabetic Retinopathy
Gilead Snaps Up Antiviral Programs From Novartis, Follows Slew Of Other Pipeline-Bolstering Deals
Roche, Novo Nordisk Top Clinical Trial Transparency Survey
New Phase 3 Interim Results Support Safety, Efficacy Of Biogen's Diroximel Fumarate In Multiple Sclerosis
Takeda Scraps Late-Stage Amyloidosis Study
FDA approves Dr. Reddy’s Tosymra
Boehringer Ingelheim Gambles $2.62 Billion On Two Fibrotic Disease Deals
Seattle Genetics, Astellas Drug Rapidly Shrinks Tumors In Bladder Cancer Study
Out From Under Novartis, Alcon Is Its Own Company Now
Ireland Demands $1.9 Billion In Back Taxes From Perrigo
FDA Greenlights Alexion’s Soliris For Rare Autoimmune Disease
FTC loses Shire appeal, losing round in fight against citizen petition abuse
Merck's Treatment For Urinary, Abdominal Infections Receives FDA Approval
Novartis' MS Drug Gilenya Wins Chinese Approval
Bristol-Myers Squibb Plans To Divest Celgene's Psoriasis Drug
Novo Nordisk, Roche Top Clinical Trial Transparency Survey
Ad Right Top
Latest News
Opiant Expands Partnership with Sanofi
Opiant Pharmaceuticals Inc. announced an agreement with Sanofi to manufacture Opiant’s investigational agent OPNTOO4 (drinabant) for the treatment of Acute Cannabinoid Overdose.
Sanofi signs U.S. rights deal with Roche for flu treatment Tamiflu
French drugs and healthcare group Sanofi signed a rights deal with Roche for Tamiflu in the United States.
Most Commented
Sorry. No data so far.
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com. 
June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!